News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Tumor Board Tuesday on HER2 options for metastatic bladder cancer
Tumor Board Tuesday/X
Oct 29, 2024, 09:31

Tumor Board Tuesday on HER2 options for metastatic bladder cancer

Tumor Board Tuesday shared a post on X:

“It is amazing how many HER2 options there are for metastatic bladder cancer.

Join us Tuesday, 10-29-24 at 8PM ET as Matt Galsky & Eric Miller the multitude of therapies for HER2+ Bladder Cancer RT and bring others into the discussion.”

bladder cancer cancer cancer awareness cancer care Eric Miller fight against cancer Global fight against cancer HER2 Matt Galsky metastatic bladder cancer OncoDaily Oncology Tumor Board Tuesday
Special Coverage
Blog
Mar 26, 2025, 16:43
March is Kidney Cancer Awareness Month - NCI Center for Cancer Research
Drugs
Mar 26, 2025, 16:35
MARIPOSA trial results presented at ELCC25 - BREAKING from Paris
Blog
Mar 26, 2025, 16:17
We are proud to announce the renewal of our partnership with the IAEA - City Cancer Challenge
Blog
Mar 26, 2025, 15:47
ESMO has just announced the ESMO Ambassadors for this year’s ELCC - LuCE
Blog
Mar 26, 2025, 15:14
Jessie Yu: Excited for the upcoming BIOCHINA Global Forum in Seoul on September 12th
Blog
Mar 26, 2025, 15:07
1 month left to submit your abstract for SIOG 2025
Blog
Mar 26, 2025, 14:53
Pashtoon Kasi: Different lenses of looking at the same biology
Blog
Mar 26, 2025, 14:43
Tuan Thanh Nguyen: Global survey on disparities in Prostate Cancer care
Science
Mar 26, 2025, 14:35
Oscar Tahuahua: If quitting smoking gave you back 10 yrs, would you believe it?
Blog
Mar 26, 2025, 14:29
Sunil Verma: It was wonderful to visit India and our AstraZeneca India teams there
Science
Mar 26, 2025, 14:26
Yüksel Ürün: Revolution in Metastatic Melanoma
Blog
Mar 26, 2025, 14:18
David Planchard: Take home messages by Fabrice Barlesi on oncogenic treatment of localised NSCLC in 2025